Background
==========

Gammaherpesviruses are archetypal persistent viruses which are ubiquitous in both human and animal populations. The human gammaherpesviruses, Epstein-Barr virus (EBV) and Kaposi\'s Sarcoma-associated Herpesvirus (KSHV), infect respectively some 90% \[[@B1]\] and 30% \[[@B2]\] of human populations and cause several cancers \[[@B2],[@B3]\]. Although much effort has been invested on these viruses, studies of EBV or KSHV are difficult to perform directly because these viruses show limited lytic growth *in vitro*and have no well-established *in vivo*infection model. Related animal gammaherpesviruses are therefore an important source of information.

Bovine herpesvirus 4 (BoHV-4) belongs to the *Gammaherpesvirinae*subfamily, and to the *Rhadinovirus*genus \[[@B4]\]. Similarly to its human counterparts, BoHV-4 was found to be widespread in all bovine populations and to persist in the vast majority of individuals as a lifelong, asymptomatic infection \[[@B5]\]. However, in some circumstances, BoHV-4 has been associated with various clinical symptoms such as skin lesions, respiratory diseases, metritis, malignant catarrhal fever or tumors \[[@B5]\].

The virus was first isolated in Europe by Bartha *et al*. from calves with respiratory diseases \[[@B6]\] and later in North America by Mohanty *et al*. \[[@B7]\]. Besides cattle, BoHV-4 has also been detected in a variety of ruminants. In particular, BoHV-4 seems to be highly prevalent among wild African buffalo (*Syncerus caffer*) which could be considered as the natural reservoir of the virus \[[@B8]-[@B10]\]. Overall, more than 40 BoHV-4 strains have been isolated across the world. These strains can be classified in three groups: the European strains (or Movar 33/63-like strains), the American strains (or DN 599-like strains) and the African buffalo strains \[[@B9]\].

It is estimated that the taurine and buffalo strains diverged around 730,000 years ago \[[@B9]\] and that the European and North American clades diverged around 260,000 years ago \[[@B9]\]. The genome of the BoHV-4 66-p-347 North American strain has entirely been sequenced \[[@B11]\]. However, the BAC-cloned reference strain V.test \[[@B12],[@B13]\] belongs to the European clade \[[@B9],[@B14]\]. Previous studies suggested that the BoHV-4 V-test strain contains regions of high dissimilarity compared to the BoHV-4 66-p-347 strain. Indeed, the nucleotide identity between the two strains has been previously measured to be as low as 88% on the BORFB2 region \[[@B11]\]. However, the lack of a complete genomic sequence for the V.test strain prevents from drawing a general view concerning this divergence level. Therefore, the low quality of the genomic information hampers the use of the BAC-cloned BoHV-4 V.test strain as a good model for studying gammaherpesvirus biology. In this study, we have determined the genomic sequence of the BoHV-4 V.test strain and analyzed its overall differences with the available sequence of the BoHV-4 66-p-347 strain \[[@B11],[@B15]\]. The results obtained highlighted important differences between BoHV-4 66-p-347 and V.test strains. Moreover complete sequencing of the BoHV-4 V.test strain also revealed genome features potentially important in other herpesviruses.

Methods
=======

BAC sequencing
--------------

BAC DNA was purified using Qiagen large-construct kit as described by the manufacturer. The complete BAC cloned viral genome of BoHV-4 V.test strain was determined by pyrosequencing using the 454 GS FLX Titanium (Roche) high-throughput sequencer and resulted in 48,967 reads of an average read length of 265 nucleotides and a total of 12,997,275 bases. A targeted ABI-Sanger sequencing of fragments of the prDNA region was also conducted using the primers listed in Table [1](#T1){ref-type="table"}. The raw 454 data has been deposited in the NCBI Sequence Read Archive (SRA) database with accession number SRA037246.

###### 

Primers used in this study

  name          Sequence                              Coordinates according to Genbank
  ------------- ------------------------------------- ----------------------------------
  Bo1 Fwd       5\'- ATGGAGGGTGATGGATTCATG-3\'        460-440^a^
  Bo1 Rev       5\'- TTAAGGCCTCATTCCAGGAAG-3\'        272-292^a^
  Bo5 Fwd       5\'- GCTACAGAAAATGGCCAGTAAAG-3\'      20366-20342^a^
  Bo5 Rev       5\'- TCATGTCCTGAGTGGGTCTATG-3\'       19170-19191^a^
  Bo6 Fwd       5\'- ATGGTCATCCTAAATGCTCAAG -3\'      20297-20318^a^
  Bo6 Rev       5\'- TCACCTAGTGTTGCAACCCC -3\'        20497-20478^a^
  Bo7 Fwd       5\'- ATGGAGACAATTTCCATAAACTG -3\'     20994-20972^a^
  Bo7 Rev       5\'- CTAGCTGGGGTAGAGTGATC -3\'        20671-20690^a^
  ORF67.5 Fwd   5\'- ATGGCTGATGGTGATGTTTTAG -3\'      93144-93123^a^
  ORF67.5 Rev   5\'- TCAATGTTTGTCCAGAGCACT -3\'       92881-92901^a^
  Bo12 Fwd      5\'- ATGGGGGCGCTATTTGGGC -3\'         97442-97460^a^
  Bo12 Rev      5\'- TCAACTGATGAAACCCACCC -3\'        97525-97506^a^
  Bo13 Fwd      5\'- ATGCGTCTCGATGGCAAGC -3\'         98838-98856^a^
  Bo13 Rev      5\'- CTATGGTTGTTTTTTAAAGAAAATC -3\'   98981-98957^a^
  ORF75 Fwd     5\'- ATGTATCCCAGATACAGTAACA -3\'      103606-103585^a^
  ORF75 Rev     5\'- TTACATTTTATTTTTCAGACACCA -3\'    100274-100297^a^
  prDNA Fwd 1   5\'- GGAGCCCAAAACCAAAAGAG -3\'        870-889^b^
  prDNA Rev 1   5\'- CTCTTTTGGTTTTGGGCTCC -3\'        889-870^b^
  prDNA Fwd 2   5\'- CGTAGGCCTCACATTCAGC -3\'         908-926^b^
  prDNA Rev 2   5\'- GCTGAATGTGAGGCCTACG -3\'         926-908^b^
  prDNA Fwd 3   5\'- CGAGAGATGGTTCTTGCACA -3\'        940-959^b^
  prDNA Rev 3   5\'- TGTGCAAGAACCATCTCTCG -3\'        959-940^b^
  BAC Rev       5\'- TTGCCAATCCCAAAAAGAAG -3\'        9859-9878^c^

^a^according to Genbank [JN133502](JN133502) sequence (BoHV-4 V.test strain long unique region)

^b^according to Genbank [JN133504](JN133504) sequence (BoHV-4 V.test strain prDNA inner region)

^c^according to Genbank [AY665170.1](AY665170.1) sequence (pBeloBAC modified)

BoHV-4 genome LUR assembly
--------------------------

The reads were *de novo*assembled with gsAssembler (Roche), where the *E. coli*genome was used as a contaminant to filter out cellular reads \[[@B16]\]. The filtering removed 1,167 contaminant cellular reads. The *de novo*assembly yielded 11 contigs which were subsequently BLASTed against 66-p-347\'s long unique region (LUR) and polyrepetitive DNA (prDNA) -accession numbers NC_002665 and AF092919- to define their relative positions \[[@B17]\]. Contigs were assembled into a large scaffold using two previously published V.test sequences (accession numbers Z46380 and Z46385 \[[@B18]\]) overlapping contig borders. A careful comparison of the bordering contigs with the previously sequenced fragments showed a high percent identity (\> 99.99%). After verification of the quality of the assembly, the BAC sequence was removed and the genome sequence was annotated as detailed hereunder.

BoHV-4 genome prDNA assembly
----------------------------

The prDNA was determined by a hybrid 454/ABI-Sanger strategy where 17 ABI-Sanger fragments of prDNA were *de novo*assembled with the 454 reads. Briefly, in order to correctly assemble the prDNA and to disentangle different prDNA units, this second *de novo*assembly was optimized for highly repetitive segments using MIRA \[[@B19]\]. 454 reads and quality information were extracted from the raw .sff file with \'sff_extract\'. The base-calling and quality-calling for Sanger sequences were inferred from the .ab1 raw chromatogram files using \'phred\' \[[@B20],[@B21]\] and the sequences were quality-trimmed using \'lucy\' \[[@B22]\]. MIRA assembler (v 3.2.0) was used to build an assembly of the V.test genome with the following flags and options: \"-job = denovo, genome, accurate, sanger, 454 -highlyrepetitive -AS:klrs = no 454_SETTINGS -AS:urdcm = 1.1:ardml = 100\'\'. This assembly yielded a very large contig containing a complete prDNA unit, and a second contig containing an incomplete unit bearing the prDNA/prDNA junction. The complete prDNA unit was extracted from the first contig and identified as being the last prDNA unit before the LUR junction and noted prDNA-G following Bublot *et al*. \[[@B14]\]. By analysing the contig bearing the prDNA/prDNA junction in GAP4 \[[@B23]\], we determined a 518 bp fragment of the prDNA-inner unit (as named by Bublot *et al*. \[[@B14]\]) bordered on the left by lower read qualities and coverage, and on the right by the beginning of a new prDNA unit. This end was joined to the beginning (2,089 bp) of the prDNA-G unit in order to obtain a complete prDNA-inner unit (2,607 bp). We verified that this complete unit was compatible with previously published information \[[@B14]\].

BoHV-4 genome annotation
------------------------

All Open Reading Frames (ORFs) from all 6 frames were retrieved from the complete genomic sequence and matched against the Conserved Domain Database \[[@B24]\] using the position-specific scoring matrices (PSSM) based Reverse PSI-BLAST \[[@B25]\]. For all ORFs sharing the same STOP and containing a PSSM match, the smallest ORF containing the largest PSSM match was retained. 59 ORFs were thus considered evolutionarily conserved and were annotated with the corresponding matching conserved domains. Out of the 79 CDS from the previously published 66-p-347 strain, all 59 ORFs matched previously annotated 66-p-347 ORFs. The 20 remaining CDS were added by similarity to this strain and were annotated as such. Repeat segments and special features were annotated according to 66-p-347 if they were present in V.test. The complete genome sequence containing the LUR, prDNA-G and prDNA-inner were annotated and submitted to GenBank with respective accession numbers: [JN133502](JN133502), [JN133503](JN133503) and [JN133504](JN133504).

Comparative genomics analysis of 66-p-347 and V.test
----------------------------------------------------

The LUR and prDNA sequences of the 66-p-347 strain were joined into a complete genome (accession numbers NC_002665 and AF092919) and aligned against the joined LUR and prDNA-inner V.test sequences with ClustalW 2.0.10 \[[@B26]\]. Percent divergence, percent insertions and deletions, and percent G+C content were computed (i) along the alignment on a 100 bp sliding window of step 3 bp and (ii) on all individually aligned proteins. Analyses and figures were conducted using R \[[@B27]\] and the seqinr \[[@B28]\] package in combination with *ad hoc*programs written in Python and using the Biopython libraries \[[@B29],[@B30]\].

RT-PCR analysis
---------------

These experiments were performed as described elsewhere \[[@B31]\]. Briefly, subconfluent monolayers of MDBK cells were infected with BoHV4 V.test strain at a m.o.i. of 1 PFU/cell. 18 hours after infection, cytoplasmic RNA was extracted, purified and treated for RT-PCR. The cDNA products were amplified by PCR using specific primers listed in Table [1](#T1){ref-type="table"}.

Results and discussion
======================

BAC sequencing and genome assembly
----------------------------------

Pyrosequencing of herpesviral genomes is often limited by the high concentration of contaminating cellular DNA \[[@B32]\]. We therefore prepared the BoHV-4 V.test strain DNA from BAC maintained genomes and sequenced it using a high-throughput pyrosequencing approach \[[@B16]\]. This yielded 48,967 reads among which 47,800 were BoHV-4 specific (\> 97% of the reads). After assembly, the mean genome coverage was of the order of 96×. In comparison to the whole genome sequencing of another herpesvirus based on DNA isolated from virus particles, which exhibited a 13× average base pair coverage \[[@B32]\], our strategy showed a more than 7-fold increase. This is probably mainly due to the high proportion of viral to cellular reads present in our dataset. Indeed, only 1,167 *Escherichia coli*contaminant reads had to be discarded from the data, indicating less than 2.38% of contaminated reads, compared to the previously reported 62.72% contaminating cellular reads in \[[@B32]\]. Our sequencing strategy based on a BAC cloning approach, thus revealed itself very powerful in terms of contamination and subsequent coverage.

V.test genome analysis and comparison to other BoHV-4 strains
-------------------------------------------------------------

The BoHV-4 genome has a B-type structure consisting of a long unique region (LUR) flanked by several polyrepetitive DNA units (prDNA). We assembled the complete LUR of the V.test strain BoHV-4 genome into a 108,241 bp sequence. The average G+C content is of 41.21%. This value as well as the G+C% variation observed on Figure [1](#F1){ref-type="fig"} is in agreement with previously reported results on the 66-p-347 strain, namely on the high G+C content of R2a region \[[@B11]\]. The observed-to-expected CpG ratio is of 0.225 on the LUR and is compatible with the value measured on *Bos taurus*(0.234) \[[@B33]\] suggesting (i) a high degree of methylation of CpG nucleotides and (ii) similar methylation mechanisms acting on the viral and cellular genome.

![**Map of the BoHV-4 V.test strain genome and divergence with the 66-p-347 strain sequence**. The LUR of both strains have been aligned. Genome features are represented in the upper part as grey and red oriented arrows. Red arrows represent genes with an in-frame STOP codon, an early Methionine or a high divergence level in the V.test strain compared to 66-p-347. Dark (resp. light) grey arrows represent genes with (resp. without) an evolutionarily conserved domain (see Methods). The exons of spliced genes are indicated under the given gene as thin light-blue lines. Percent divergence is shown as a black-filled curve, percent insertions and deletions are shown as a blue-filled curve. Percent G+C content is shown as a thin green curve, with the mean G+C content drawn as a thin horizontal green line. These percentages are measured in a 100 bp window sliding 3 bp. Repeat regions (R1, R2a, R2b) are depicted as hatched areas. The *oriLyt*region is mapped as a light-grey area within R2b and the conserved quasi-palindromic motif in the *oriLyt*region is indicated by a small vertical arrow.](1743-422X-8-406-1){#F1}

As expected, the nucleotide identity between our assembled genome and previously published V.test strain sequence data was of 99.55% in average, falling into the ranges of comparison between 454 and Sanger sequencing \[[@B34]\].

Compared to the 66-p-347 strain, the V.test strain had previously shown divergence up to 12% on the region surrounding BORFB2 (ORF 16, v-Bcl-2) \[[@B11]\]. However, the lack of a complete genomic sequence for the V.test strain prevented from drawing a general conclusion concerning this divergence level. Compared to 66-p-347 strain, the overall V.test nucleotide identity is high (99.1%), but shows a large variability at the genome level (Figure [1](#F1){ref-type="fig"}). As expected, the repetitive regions contained in the LUR (R1, R2a and R2b) exhibit a high nucleotide divergence, up to more than 40%, as well as large gaps (Figure [1](#F1){ref-type="fig"}). This indicates that the very high divergence levels seem confined to specific repetitive genomic regions. However, some rather high divergence levels were also identified in other regions (Figure [1](#F1){ref-type="fig"}) and namely in ORF-containing regions such as ORF 10, Bo5, ORF 57, and ORF 68 region. We also note a large deletion and a high divergence at the beginning of the LUR compared to the 66-p-347 strain. Overall, these differences in protein-coding region as well as in repetitive regions that bear predicted microRNA coding sequences \[[@B35]\] will require specific experiments to identify possible links with observed phenotypic differences between strains.

Conserved protein-coding genes
------------------------------

In order to develop an *ab initio*approach of gene annotation, we extracted all possible ORFs in all 6 frames from the complete genomic sequence of the BoHV-4 V.test strain. On each of these ORFs, we ran a Reverse PSI-BLAST \[[@B25]\] against all protein domains from the Conserved Domain Database \[[@B24]\]. ORFs containing an evolutionarily conserved domain were defined as the smallest ORF containing the longest CDD match (see Methods). This approach revealed 59 ORFs containing a conserved CDD domain (Table [2](#T2){ref-type="table"}). All 59 detected ORFs corresponded to ORFs previously annotated in the 66-p-347 strain (on a total of 79 ORFs listed in Table [3](#T3){ref-type="table"}), indicating that 75% of BoHV-4 ORFs contain conserved domains. Most of these ORFs (37/59) contain domains that are either conserved at different levels in the Herpesvirales (either gammaherpesvirinae, herpesviridae or herpesvirales), or at a much larger scale that include Eukaryota, Bacteria and Archaea (22/59) (Table [2](#T2){ref-type="table"}). This second set of genes might bear good candidates for genes having been the stage of lateral gene transfer events as observed for several herpesvirus genes \[[@B36]\] such as the BoHV-4 Bo17 gene that encodes a homologue of the cellular core 2 beta -1,6-N-acetylglucosaminyl-transferase M \[[@B37]\]. These results will deserve further studies to identify the evolutionary history responsible for these observations.

###### 

Potential BoHV-4 V.test ORFs presenting conserved functional domains

  BoHV-4 ORF   Domain accession number                                                 Functional annotation                                                              **Species distribution**^**a**^
  ------------ ----------------------------------------------------------------------- ---------------------------------------------------------------------------------- -------------------------------------------
  ORF 3        COG0046, TIGR01735, TIGR01736, TIGR01739, PF02769                       Phosphoribosylformylglycinamidine (FGAM) synthase; AIR synthase related protein    Eukaryota; Bacteria; Archaea; Viruses
  ORF 6        PF00747                                                                 ssDNA binding protein                                                              Herpesviridae
  **ORF 7**    **PF01366**                                                             **Protein transporter activity**                                                   **Herpesviridae**
  **ORF 8**    **PF00606**                                                             **Surface glycoprotein**                                                           **Herpesviridae**
  ORF 9        COG0417, TIGR00592, PF00136, PF03104, SM00486                           DNA polymerase type-B family                                                       Eukaryota; Bacteria; Archaea; Viruses
  ORF 10       PF04797                                                                 dUTPase                                                                            Herpesviridae
  Bo4          COG5183, SM00744                                                        Protein involved in mRNA turnover and stability; zinc-finger RING-variant domain   Eukaryota; Bacteria
  ORF 16       SM00337                                                                 BCL (B-Cell lymphoma); contains BH1, BH2 regions                                   Eukaryota; Bacteria; Viruses
  **ORF 17**   **PF00716**                                                             **Serine-type endopeptidase activity**                                             **Herpesviridae**
  ORF 18       PF03049                                                                 UL79 family                                                                        Herpesviridae
  **ORF 19**   **PF01499**                                                             **Virus penetration and capsid assembly**                                          **Herpesviridae**
  **ORF 20**   **PF01646**                                                             **UL24 family**                                                                    **Herpesviridae**
  ORF 21       PF00693, PF01712, PF08465                                               ATP binding; thymidine kinase activity; phosphotransferase activity                Eukaryota; Bacteria; Viruses
  **ORF 22**   **PF02489**                                                             **Virion associated envelope glycoprotein**                                        **Herpesviridae**
  ORF 23       PF04682                                                                 BTRF1 protein conserved region                                                     Herpesviridae
  ORF 24       PF03043                                                                 UL87 family                                                                        Herpesviridae
  ORF 25       PF03122                                                                 Structural molecule activity                                                       Herpesvirales
  **ORF 26**   **PF01802**                                                             **Structural molecule activity**                                                   **Herpesvirales**
  ORF 29       PF02499, PF02500                                                        Probable role in DNA packaging                                                     Herpesvirales
  ORF 30       PF05338                                                                 Unknown function (DUF717)                                                          Gammaherpesvirinae
  ORF 31       TIGR01234, PF03048                                                      UL92 family; L-ribulokinase                                                        Herpesvirales; Embryophyta
  ORF 32       PF04559                                                                 DNA cleavage and packaging                                                         Herpesviridae
  ORF 33       PF03044                                                                 Possible role in capsid maturation                                                 Herpesviridae
  ORF 34       PF03038                                                                 UL95 family                                                                        Herpesviridae
  ORF 35       PF05852                                                                 Unknown function (DUF848)                                                          Gammaherpesvirinae
  **ORF 36**   **COG0515, PF00069, SM00220**                                           **ATP binding; protein kinase activity; Serine/threonine protein kinase**          **Eukaryota; Bacteria; Archaea**
  **ORF 37**   **PF01771, PF09588**                                                    **Exonuclease activity; DNA binding**                                              **Eukaryota; Bacteria; Viruses**
  ORF 38       PF10813                                                                 Unknown function (DUF2733)                                                         Herpesviridae
  **ORF 39**   **PF01528**                                                             **Integral membrane protein**                                                      **Herpesviridae**
  ORF 40       PF03324                                                                 Helicase-primase complex associated protein                                        Herpesviridae
  ORF 41       PF05774                                                                 Helicase-primase complex components                                                Gammaherpesvirinae
  **ORF 42**   **PF01677**                                                             **UL7-like protein**                                                               **Herpesviridae**
  **ORF 43**   **PF01763**                                                             **Possible role in cleavage and packaging**                                        **Herpesviridae**
  **ORF 44**   **COG0507, PF02689**                                                    **Helicase; ATP-dependent exoDNAse (exonuclease V)**                               **Eukaryota; Bacteria; Viruses**
  **ORF 46**   **COG0692, TIGR00628, TIGR03443, PF03167**                              **Uracil DNA glycosylase**                                                         **Eukaryota; Bacteria; Archaea; Viruses**
  ORF 47       PF11108                                                                 Glycoprotein L                                                                     Herpesviridae
  ORF 48       PF05734                                                                 Unknown function (DUF832)                                                          Herpesviridae
  ORF 50       PF03326, PF04793                                                        Early-intermediate transcription factors                                           Gammaherpesvirinae
  **Bo10**     **PF05459, PF05812**                                                    **Transcriptional regulator proteins**                                             **Herpesviridae**
  ORF 53       PF03554                                                                 Highly polymorphic glycoprotein                                                    Herpesviridae
  **ORF 54**   **COG0756, TIGR00576, PF00692**                                         **dUTPase**                                                                        **Eukaryota; Bacteria; Archaea; Viruses**
  ORF 55       PF04533                                                                 U44 protein                                                                        Herpesviridae
  **ORF 56**   **PF03121**                                                             **UL52/UL70 DNA primase**                                                          **Eukaryota; dsDNA Viruses**
  ORF 57       PF04633                                                                 BMRF2 protein                                                                      Gammaherpesvirinae
  ORF 59       PF04929                                                                 DNA replication accessory factor                                                   Gammaherpesvirinae
  ORF 60       COG0208, PF00268                                                        Ribonucleotide reductase                                                           Eukaryota; Bacteria; Archaea; Viruses
  **ORF 61**   **COG0209, TIGR02504, TIGR02506, TIGR02510, PF00317, PF02867**          **Ribonucleotide reductase**                                                       **Eukaryota; Bacteria; Archaea; Viruses**
  ORF 62       PF03327                                                                 Capsid shell protein VP19C                                                         Herpesviridae
  ORF 63       PF04523                                                                 Tegument protein U30                                                               Herpesviridae
  ORF 64       PF04843                                                                 Tegument protein, N-terminal conserved region                                      Herpesviridae
  ORF 65       PF06112                                                                 Capsid protein                                                                     Gammaherpesvirinae
  ORF 66       PF03117                                                                 UL49 family                                                                        Herpesviridae
  ORF 67       PF04541                                                                 Virion protein U34                                                                 Herpesviridae
  ORF 67.5     PF03581                                                                 UL33-like protein                                                                  Herpesviridae
  **ORF 68**   **PF01673**                                                             **Putative major envelope glycoprotein**                                           **Herpesviridae**
  **ORF 69**   **PF02718**                                                             **UL31-like protein**                                                              **Herpesviridae**
  ORF 71       PF01335, SM00031                                                        Death effector domain                                                              Eukaryota; Viruses
  ORF 75       COG0046, COG0047, TIGR01735, TIGR01736, TIGR01739, TIGR01857, PF02769   Phosphoribosylformylglycinamidine (FGAM) synthase; AIR synthase related protein    Eukaryota; Bacteria; Archaea; Viruses
  Bo17         PF02485                                                                 Core-2/I-Branching enzyme                                                          Eukaryota; Bacteria; Viruses

Conserved functional domains were determined for each BoHV-4 V.test ORF using METHOD and the domains accession numbers, functional annotation and the species distribution were listed. When several domains were conserved, the annotations were either merged when possible or juxtaposed. Domains present in herpesviridae conserved gene families are highlighted in bold (*from Fu, 2008*). (PFxxx: Pfam Accession Number; SMxxx: SMART Accession Number; COGxxx: COG Accession Number; TIGRxxx: TIGRFam Accession Number).

^a^Major taxonomic groups.

###### 

Potential BoHV-4 V.test ORFs and homologues to HHV-8 and HHV-1

  BoHV-4 ORF       Strand    **Start**^**a**^   **Stop**^**a**^   **HHV-8 homologue**^**b**^   **HHV-1 homologue**^**c**^   Annotation and comments
  ---------------- --------- ------------------ ----------------- ---------------------------- ---------------------------- -----------------------------------------------------------------------
  Bo1              \-        272                460               *\--*                        *\--*                        Early in-frame STOP codon
  ***ORF 3***      ***+***   ***441***          ***4307***        ***\--***                    ***\--***                    ***BORFA1; v-FGAM-synthase***
  Bo2              \+        4435               4638              *\--*                        *\--*                        
  Bo3              \+        5072               5299              *\--*                        *\--*                        
  ***ORF 6***      ***+***   ***5703***         ***9107***        ***ORF 6***                  ***UL 29***                  ***single-stranded DNA-binding protein MDBP***
  **ORF 7**        **+**     **9112**           **11190**         **ORF 7**                    **UL 28**                    **transport protein**
  **ORF 8**        **+**     **11180**          **13804**         **ORF 8**                    **UL 27**                    **glycoprotein B**
  ***ORF 9***      ***+***   ***13944***        ***16961***       ***ORF 9***                  ***UL 30***                  ***DNA polymerase***
  ***ORF 10***     ***+***   ***17057***        ***18337***       ***ORF 10***                 ***\--***                    ***BORFB1***
  ***Bo4***        ***-***   ***18604***        ***19101***       ***\--***                    ***\--***                    ***short ORF of immediate early transcript 1***
  Bo5              \-        19170              20355             K5                           \--                          long ORF of immediate early transcript 1
  Bo6              \+        20297              20590             \--                          \--                          Early in-frame STOP codon
  Bo7              \-        20670              20994             \--                          \--                          Disrupted frame
  Bo8              \+        21318              21521             \--                          \--                          overlapping with late 1.7 kb RNA
  ***ORF 16***     ***+***   ***22967***        ***23647***       ***ORF 16***                 ***\--***                    ***BORFB2; v-Bcl-2 protein***
  **ORF 17**       **-**     **23710**          **25260**         **ORF 17**                   **UL 26**                    **capsid protein**
  ***ORF 18***     ***+***   ***25259***        ***26077***       ***ORF 18***                 ***\--***                    
  **ORF 19**       **-**     **26029**          **27705**         **ORF 19**                   **UL 25**                    **tegument protein**
  **ORF 20**       **-**     **27407**          **28219**         **ORF 20**                   **UL 24**                    
  ***ORF 21***     ***+***   ***28203***        ***29540***       ***ORF 21***                 ***UL 23***                  ***thymidine kinase***
  **ORF 22**       **+**     **29551**          **31674**         **ORF 22**                   **UL 22**                    **glycoprotein H**
  ***ORF 23***     ***-***   ***31671***        ***32873***       ***ORF 23***                 ***\--***                    
  ***ORF 24***     ***-***   ***32851***        ***35109***       ***ORF 24***                 ***\--***                    
  ***ORF 25***     ***+***   ***35099***        ***39220***       ***ORF 25***                 ***UL 19***                  ***major capsid protein***
  **ORF 26**       **+**     **39256**          **40170**         **ORF 26**                   **UL 18**                    **capsid protein**
  ORF 27           \+        40184              40829             ORF 27                       \--                          
  Bo9              \+        40831              41130             *\--*                        *\--*                        
  ***ORF 29***     ***-***   ***41154***        ***46328***       ***ORF 29***                 ***UL 15***                  ***cleavage/packaging protein***
  ***ORF 30***     ***+***   ***42306***        ***42548***       ***ORF 30***                 ***\--***                    
  ***ORF 31***     ***+***   ***42482***        ***43123***       ***ORF 31***                 ***\--***                    
  ***ORF 32***     ***+***   ***43069***        ***44439***       ***ORF 32***                 ***UL 17***                  ***viral DNA cleavage/packaging protein***
  ***ORF 33***     ***+***   ***44432***        ***45430***       ***ORF 33***                 ***UL 16***                  
  ***ORF 34***     ***+***   ***46327***        ***47313***       ***ORF 34***                 ***\--***                    
  ***ORF 35***     ***+***   ***47285***        ***47758***       ***ORF 35***                 ***\--***                    
  **ORF 36**       **+**     **47787**          **48950**         **ORF 36**                   **UL 13**                    **kinase**
  **ORF 37**       **+**     **48958**          **50427**         **ORF 37**                   **UL 12**                    **alkaline exonuclease**
  ***ORF 38***     ***+***   ***50379***        ***50585***       ***ORF 38***                 ***\--***                    
  **ORF 39**       **-**     **50652**          **51761**         **ORF 39**                   **UL 10**                    **glycoprotein M**
  ***ORF 40***     ***+***   ***51877***        ***53247***       ***ORF 40***                 ***UL 8***                   ***helicase-primase complex component***
  ***ORF 41***     ***+***   ***53360***        ***53881***       ***ORF 41***                 ***\--***                    ***helicase-primase complex component***
  **ORF 42**       **-**     **53873**          **54748**         **ORF 42**                   **UL 7**                     
  **ORF 43**       **-**     **54525**          **56375**         **ORF 43**                   **UL 6**                     **capsid protein**
  **ORF 44**       **+**     **56323**          **58701**         **ORF 44**                   **UL 5**                     **helicase**
  ORF 45           \-        58805              59530             ORF 45                       \--                          
  **ORF 46**       **-**     **59530**          **60291**         **ORF 46**                   **UL 2**                     **uracil-DNA-glycosidase**
  ***ORF 47***     ***-***   ***60309***        ***60731***       ***ORF 47***                 ***\--***                    ***glycoprotein L***
  ***ORF 48***     ***-***   ***60838***        ***62382***       ***ORF 48***                 ***\--***                    
  ***ORF 50***     ***+***   ***62586***        ***65179***       ***ORF 50***                 ***\--***                    ***immediate early transcript 2; R transactivator protein***
  ORF 49           \-        62600              63499             ORF 49                       \--                          
  **Bo10**         **+**     **65696**          **66595**         **\--**                      **UL 54**                    **glycoprotein gp80**
  ORF 52           \-        66621              67007             ORF 52                       \--                          
  ***ORF 53***     ***-***   ***67073***        ***67345***       ***ORF 53***                 ***\--***                    
  **ORF 54**       **+**     **67414**          **68262**         **ORF 54**                   **UL 50**                    **dUTPase**
  ***ORF 55***     ***-***   ***68321***        ***68923***       ***ORF 55***                 ***\--***                    
  **ORF 56**       **+**     **68887**          **71418**         **ORF 56**                   **UL 52**                    **DNA replication protein**
  ***ORF 57***     ***+***   ***71512***        ***72870***       ***ORF 57***                 ***\--***                    ***possible post-transcriptional transactivator***
  ORF 58           \-        73294              74346             ORF 58                       \--                          
  ***ORF 59***     ***-***   ***74360***        ***75535***       ***ORF 59***                 ***\--***                    ***DNA replication protein***
  ***ORF 60***     ***-***   ***75688***        ***76605***       ***ORF 60***                 ***UL 40***                  ***ribonucleotide reductase small subunit***
  **ORF 61**       **-**     **76639**          **79020**         **ORF 61**                   **UL 39**                    **ribonucleotide reductase large subunit**
  ***ORF 62***     ***-***   ***79002***        ***80021***       ***ORF 62***                 ***UL 38***                  ***assembly/DNA maturation protein***
  ***ORF 63***     ***+***   ***79978***        ***82797***       ***ORF 63***                 ***\--***                    ***tegument protein***
  ***ORF 64***     ***+***   ***82812***        ***90488***       ***ORF 64***                 ***UL 36***                  ***tegument protein***
  ***ORF 65***     ***-***   ***90504***        ***90896***       ***ORF 65***                 ***\--***                    ***capsid protein***
  ***ORF 66***     ***-***   ***90893***        ***92167***       ***ORF 66***                 ***\--***                    
  ***ORF 67***     ***-***   ***92107***        ***92877***       ***ORF 67***                 ***UL 34***                  ***tegument protein***
  ***ORF 67.5***   ***-***   ***92881***        ***93144***       ***ORF 67.5***               ***UL 33***                  ***Disrupted (late) methionine***
  **ORF 68**       **+**     **93155**          **94504**         **ORF 68**                   **UL 32**                    **probable glycoprotein**
  **ORF 69**       **+**     **94512**          **95405**         **ORF 69**                   **UL 31**                    
  Bo11             \-        96158              96703             \--                          \--                          
  Bo12             \+        97442              97684             \--                          \--                          Early in-frame STOP codon
  ***ORF 71***     ***-***   ***98328***        ***98876***       ***K13/ORF 71***             ***\--***                    ***BORFE2; v-FLIP***
  Bo13             \+        98838              98983             \--                          \--                          Disrupted frame
  ORF 73           \-        99022              99783             ORF 73                       \--                          BORFE3, LANA homologous
  ***ORF 75***     ***-***   ***100274***       ***103606***      ***ORF 75***                 ***\--***                    ***Disrupted (late) methionine; tegument protein/v-FGAM-synthetase***
  Bo14             \-        104273             104785            *\--*                        *\--*                        
  Bo15             \-        105724             106038            *\--*                        *\--*                        
  Bo16             \+        106225             106494            *\--*                        *\--*                        
  ***Bo17***       ***+***   ***106681***       ***108003***      ***\--***                    ***\--***                    ***viral beta-1,6-N-acetylglucosaminyltransferase***

^a^Positions of the respective ORFs of BoHV-4 on the LUR sequence. These are given from the first nucleotide of the start codon ATG to the last nucleotide of the stop codon.

^b^Correspondance to HHV-8 genes is according to Zimmermann (2001).

^c^Correspondance to HHV-1 genes was based on the presence of conserved domain with a BoHV-4 gene. Genes containing evolutionary conserved domains are highlighted in bold italic. The genes conserved in Herpesviridae are highlighted in bold (*from Fu, 2008*).

Non-conserved protein-coding genes
----------------------------------

The remaining 20 annotated ORFs were determined by similarity to the 66-p-347 strain, and correspond for most of them to ORFs unique to BoHV-4 as described previously (Table [3](#T3){ref-type="table"}) \[[@B11]\]. Some of these ORFs, however, contain odd characteristics that needed to be investigated (Figure [2](#F2){ref-type="fig"}, Additional file [1](#S1){ref-type="supplementary-material"} Figures S1-9). Indeed Bo1, Bo6, Bo7, Bo12 and Bo13 genes of the BoHV-4 V.test strain present in-frame STOP codons. Bo5 presents rather high divergency levels and large insertions/deletions (\> 5% of its coding sequence as shown in Figure [2](#F2){ref-type="fig"}) compared to the genomic sequence of the 66-p-347 strain. Moreover, ORFs 36, 67.5 and 75, which bear an evolutionary conserved domain, present late methionines compared to the 66-p-347 annotation. Indeed, in ORF 36 (see Additional file [1](#S1){ref-type="supplementary-material"} Figures S5), the smallest ORF containing an evolutionary conserved domain is slightly shorter than the one annotated in 66-p-347 and there is no evidence that the previously annotated methionine is the correct one. However, comparison with homologous genes in other rhadinoviruses suggests that the start codon proposed in the 66-p-347 annotated sequence is the most likely. In ORF 67.5 (see Additional file [1](#S1){ref-type="supplementary-material"} Figures S6), there is a point substitution in the 66-p-347 annotated ATG leading to the identification of a subsequent ATG as the V.test methionine. Finally, ORF 75 presents a small phase-disrupting indel in its 5\' end (see Additional file [1](#S1){ref-type="supplementary-material"} Figures S9), leading to the absence of the 66-p-347 annotated methionine in the V.test strain. All these annotated genes requested therefore an investigation of their transcription in mRNA products.

![**Proteins in V.test: divergence with the previously published 66-p-347 strain**. Percentage divergence and percentages indels on the aligned amino-acid sequences are represented as, respectively, black and light-blue bars. The dotted black line represents a 5% threshold. Genes containing an evolutionarily conserved domain (see Methods) are represented on a light-grey background. Previously annotated genes presenting in the V.test strain an in-frame stop codon, a late Methionine or large divergence levels compared to the 66-p-347 strain are indicated in red.](1743-422X-8-406-2){#F2}

As these sequence properties could be specific to the BAC clone of the BoHV-4 V.test strain, we investigated the transcription of these genes on MDBK cells infected with the BoHV-4 V.test WT strain as described in the methods. The primers used are described in Table [1](#T1){ref-type="table"} and highlighted in Additional file [1](#S1){ref-type="supplementary-material"}. For all couple of primers, cDNA from BoHV-4-infected MDBK cells gave rise to the expected PCR products (Figure [3](#F3){ref-type="fig"}). The absence of contaminant viral DNA in the mRNA preparations was confirmed by a lack of PCR product without reverse transcriptase. The size of the Bo5 RT-PCR product was also consistent with its known mRNA splicing (868 bp rather than 1140 bp). Moreover, the sequences of these RT-PCR products were in agreement with the BoHV-4 V.test sequence derived from our BAC cloned genome (data not shown). Therefore, we can conclude that all these coding sequences are transcribed during BoHV-4 infection of MDBK cells. However, further investigation is needed to determine the presence of proteins and ensure their accurate annotation.

![**RT-PCR amplification of the coding regions of the genes Bo1, Bo5, Bo6, Bo7, ORF67.5, Bo12, Bo13 and ORF75 of the BoHV-4 V.test strain**. Subconfluent monolayers of MDBK cells were infected with BoHV4 V.test strain at a m.o.i. of 1 PFU/cell. 18 hours after infection, cytoplasmic RNA was extracted, purified and treated for RT-PCR. The cDNA products were amplified by PCR using specific primers listed in Table 1.](1743-422X-8-406-3){#F3}

BoHV-4 V.test replication origin
--------------------------------

A large region containing the potential lytic replication origin (*oriLyt*) of the BoHV-4 66-p-347 strain was determined by Zimmermann *et al*\[[@B11]\]. Based on this information, we mapped this region on the V.test genome (Figure [1](#F1){ref-type="fig"}). This region contains Bo12, the R2b region and partially overlaps with Bo11. Compared to the 66-p-347 strain sequence, the corresponding region in the V.test genome is highly divergent (Figure [4](#F4){ref-type="fig"}). Although this region shows high divergence rates, we expected the replication origin to be conserved between the two BoHV-4 strains. Previous work on other herpesviruses has identified in *oriLyt*the presence of palindromic motifs essential for viral replication \[[@B38]-[@B40]\]. When we compared the potential region containing *oriLyt*in the two strains, a single conserved palindromic region was observed (AATCCAGGCCCCTGATTGGTAGATTGCTGAAAGCCAATCAGGGGCCTGGATT, Figure [4](#F4){ref-type="fig"}). Interestingly, this region forms a perfect hairpin structure (Figure [4B](#F4){ref-type="fig"}) that resembles DNA structures formed at other herpesvirus origins \[[@B41],[@B42]\] and may therefore represent a common secondary structure used by all herpesvirus family members during the initiation of DNA replication. In the future, this structure will be tested as a candidate for an essential *oriLyt*replication motif.

![**Prediction of BoHV-4 V.test OriLyt**. A. Alignment of the V.test strain (above) and 66-p-347 strain (below) regions predicted to contain the OriLyt in the 66-p-347 strain. The differences observed in the alignment are highlighted in light grey. The predicted potential OriLyt is highlighted in dark grey. B. The predicted secondary structures of the top (+) and bottom (-) strands of the predicted BoHV-4 OriLyt sequence were analyzed using the Vienna RNA website program RNAfold with DNA parameters. The predicted free energy (ΔG) of each structure is given, as well as the positional entropy of each nucleotide.](1743-422X-8-406-4){#F4}

BoHV-4 V.test polyrepetitive DNA
--------------------------------

In the BAC clone, previous restriction profiles had determined a hypermolar prDNA band indicating that the BAC contained several prDNA units \[[@B12]\]. Therefore, the major pitfall in the assembly of the BoHV-4 V.test strain was the determination of the prDNA sequence. Indeed, (i) the higher per base coverage on this region due to repetition of prDNA units, (ii) the high GC content, along with (iii) the presence of several long repeats within the prDNA and (iv) the variability observed between prDNA units \[[@B14]\] made it extremely difficult to resolve and assemble with pyrosequencing data alone. Interestingly, it has been shown for several rhadinoviruses that the left junction between the prDNA and the LUR is the site of genome rearrangements and that sequences of the prDNA are found within the first base pairs of the LUR. These properties make this region very difficult to sequence \[[@B43]-[@B47]\].

Therefore, we adopted a hybrid strategy consisting in adding some ABI-Sanger reads (with the primers described in Table [1](#T1){ref-type="table"}) to guide the 454 assembly on the prDNA region (see Methods).

Bublot, *et al*. \[[@B14]\] described the different prDNA unit variants present in BoHV-4 V.test, and namely the differences between prDNA units. Firstly, the prDNA units vary according to the number of repetitions of a \~200 bp Pst-I bordered fragment. Secondly, the last prDNA before the prDNA/LUR junction (prDNA-G) displays a different ending than the inner prDNA units \[[@B14]\]. Our method allowed us to disentangle the repeats and to assemble a contig containing a whole prDNA unit (2,440 bp) along with the left prDNA-LUR junction. This prDNA unit, corresponding to prDNA-G following Bublot *et al*. \[[@B14]\], was extracted from the contig and annotated. A second contig from this hybrid assembly yielded the prDNA/prDNA junction. The presence of the prDNA/prDNA junction in our assembly confirmed the presence of at least two prDNA units in our BAC clone and allowed us to build a complete prDNA-inner unit (see Methods). The assembled prDNA-G and inner prDNA units have sizes of 2,440 bp and 2,607 bp respectively. Both these units are in agreement with their previously published restriction maps \[[@B14]\].

Specifically, we showed that, comparatively to the 66-p-347 strain, the V.test prDNA-inner unit presents several indels including two large indels in the repetitive PstI region (Figure [5](#F5){ref-type="fig"}). This PstI-rich repetitive region seems to be the one presenting the most variation as it also presents comparatively large differences between prDNA units within the same strain. Indeed, Bublot *et al*. \[[@B14]\] roughly determined the size of the V.test major prDNA-inner unit to be around 2,650 bp due to the presence of 4 repetitions of the two small PstI bordered fragments.

![**The BoHV-4 inner prDNA units contain conserved cleavage/packaging signals**. Alignment of the prDNA-inner units from V.test strain (above) and 66-p-347 strain (below). The differences observed in the alignment are highlighted in grey. The cleavage/packaging signals *pac-1*and *pac-2*are represented in boxes, and their composing C-rich, G-rich, GC-rich and T-rich units are indicated. PstI, EcoRI, SstII, BamHI restriction sites are represented in coloured font.](1743-422X-8-406-5){#F5}

In the prDNA-G unit, we established that these two small PstI-bordered fragments make up a fragment of 186 bp and that these are indeed repeated 4 times (Figure [6](#F6){ref-type="fig"}). In the prDNA-inner unit, we determined that the last PstI-bordered fragment is actually a variation of the 186 bp fragment where the inner Pst-I site is slightly modified (Figure [6](#F6){ref-type="fig"}). Therefore, the rough 200 bp size discrepancy between the prDNA-G (2,440 bp) and the prDNA-inner units (2,607 bp) is due to the presence of a slightly modified repetition of the previous segment. These results are compatible with the restriction profiles presented in Bublot *et al*. \[[@B14]\] as detailed by the positions of several restriction sites on Figure [6](#F6){ref-type="fig"}.

![**The prDNA-G unit does not present a complete *pac-2*cleavage/packaging signal**. Alignment of the prDNA units from V.test strain (prDNA-inner above and prDNA-G below). The differences observed in the alignment are highlighted in grey. The cleavage/packaging signals *pac-1*and *pac-2*are represented in boxes, and their composing C-rich, G-rich, GC-rich and T-rich units are indicated. PstI, EcoRI, SstII, BamHI restriction sites (here PstI) are represented in coloured font. One modified PstI restriction site in the prDNA-inner is also highlighted to indicate the divergence between the fragments composing both units.](1743-422X-8-406-6){#F6}

In addition to the variations in the PstI-bordered repetitions, one of the major differences between the prDNA-inner units and the prDNA-G lies in their 5\' end. Indeed, the prDNA-inner contains a conserved *pac-2*cleavage/packaging signal in its right terminal region, which is not the case of prDNA-G (Figure [6](#F6){ref-type="fig"}). Both units however, possess a conserved *pac-1*cleavage/packaging signal in their left terminal region. Interestingly, the *pac-1*and *pac-2*cleavage and packaging signals show a good conservation between 66-p-347 and V.test\'s inner units, despite the presence of these signals in a repeated region bearing high divergence levels. Broll et al. \[[@B15]\] have determined, by transient cleavage/packaging assay, that a single prDNA unit is sufficient for cleavage and packaging. However, from the absence of a conserved *pac-2*motif in the prDNA-G, we suggest that, even if a single inner prDNA unit is indeed sufficient for cleavage and packaging, the prDNA-G alone would not suffice. This would therefore indicate that two prDNA units at least are necessary in the context of naturally occurring BoHV-4 genomes for correct cleavage and packaging. The packaging of herpesvirus genomes is still not fully understood, however, detailed studies in herpes simplex virus type 1 (HSV-1), human and murine cytomegaloviruses (HCMV and MCMV) have highlighted the roles of the major conserved motifs and suggested the following general mechanism by which concatemers are cleaved and packaged \[[@B48]-[@B50]\]. Firstly, the T-box of the *pac-2*signal is essential for the cleavage that initiates DNA packaging. Cleavage occurs at a fixed distance from the *pac-2*T-box, and the resulting end that contains the *pac-2*GC-box and other cis acting elements is inserted into the procapsid. Packaging is therefore directional and proceeds from *pac-2*towards the *pac-1*terminus \[[@B48]\]. A second cleavage event, directed by *pac-1*, then terminates DNA packaging. If we apply this model to BoHV-4, the divergence of the *pac-2*signal in prDNA-G, namely the absence of a T-box, indicates that it is not a functional *pac-2*initiation signal. As the genome packaging is directional from *pac-2*to *pac-1*(therefore, from the right to the left end of the genome), the lack of a *pac-2*initiation signal in prDNA-G ensures that no packaging would lead to a remaining concatemer lacking a left end prDNA. This would therefore guarantee that genomes bearing at least one left and one right end prDNA unit are encapsulated into virions. This model and its implications will require further investigations in the future.

Conclusions
===========

BAC-cloning of the BoHV-4 V.test strain has greatly facilitated the use of this virus as a model for human pathogenic gammaherpesviruses. However, until now, the complete genome sequence of this strain was unavailable. In this study, we have determined the complete genome sequence of the BoHV-4 V.test strain. In comparison with the previously sequenced 66-p-347 strain, we identified important differences in 9 potential open reading frames. Moreover, sequence analyses allowed us to identify genome features that are potentially important for viral replication. All together, these results should have implications for the study of BoHV-4 and herpesviruses in general.
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